The main differences of the impact of higher levels of NFATc3 on airway remodeling scores work through disease with both IPF and severe COPD patients exhibiting lower remodeling outcomes relative to less severely ill COPD patients. Here, NFATC3 is linked to idiopathic pulmonary fibrosis.